Cogent Biosciences, Inc. (COGT)
33.38
-1.23
(-3.55%)
USD |
NASDAQ |
Mar 20, 16:00
33.90
+0.52
(+1.56%)
Pre-Market: 08:45
Cogent Biosciences EPS Diluted (Quarterly) : -0.6934 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Terns Pharmaceuticals, Inc. | -0.2686 |
| Nuvalent, Inc. | -1.585 |
| Sarepta Therapeutics, Inc. | -3.934 |
| BridgeBio Pharma, Inc. | -0.9964 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -102.49M |
| Total Expenses (Quarterly) | 102.49M |
| Enterprise Value | 4.845B |
| Earnings Yield | -7.34% |
| Normalized Earnings Yield | -7.234 |